![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » FDA Warns Florida Firm for Selling Unapproved Drugs
FDA Warns Florida Firm for Selling Unapproved Drugs
June 2, 2021
The FDA has issued a warning letter to OCLO Nanotechnology Science, a Florida-based biotech, for selling unapproved drug products marketed as COVID-19 treatments.
The unapproved chlorine dioxide products include OCLO 3000, marketed as an antiviral immune booster, “misleadingly” represented as safe and effective for treating or preventing COVID-19, the agency said.
The agency noted that it is illegal to advertise that a drug can treat a disease unless it is approved based on “competent and reliable scientific evidence,” but no such study is currently known to exist for the products in question.
Upcoming Events
-
21Oct